- Report
- February 2026
- 250 Pages
Global
From €3953EUR$4,490USD£3,419GBP
- Report
- January 2026
- 185 Pages
Global
From €3961EUR$4,500USD£3,427GBP
- Report
- September 2025
- 70 Pages
Global
From €3500EUR$4,259USD£3,134GBP
- Report
- May 2021
- 177 Pages
United States
€1316EUR$1,495USD£1,139GBP
- Report
- February 2025
- 100 Pages
Global
From €5238EUR$5,950USD£4,531GBP
- Report
- October 2022
- 119 Pages
Global
From €3961EUR$4,500USD£3,427GBP
- Report
- January 2024
- 200 Pages
Global
From €3653EUR$4,150USD£3,161GBP
- Report
- October 2023
- 145 Pages
Global
From €2773EUR$3,150USD£2,399GBP
- Report
- March 2025
- 290 Pages
Global
From €3953EUR$4,490USD£3,419GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1761EUR$2,000USD£1,523GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1761EUR$2,000USD£1,523GBP
- Report
- February 2023
- 198 Pages
Global
From €6602EUR$7,500USD£5,712GBP
- Report
- February 2023
- 99 Pages
Global
From €3477EUR$3,950USD£3,008GBP
- Report
- March 2025
- 185 Pages
Global
From €3961EUR$4,500USD£3,427GBP
- Report
- June 2024
- 200 Pages
Global
From €6999EUR$7,950USD£6,054GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4358EUR$4,950USD£3,770GBP
- Report
- February 2024
- 120 Pages
Global
From €4182EUR$4,750USD£3,617GBP
- Report
- January 2025
- 144 Pages
Global
From €3477EUR$3,950USD£3,008GBP
- Report
- September 2022
- 149 Pages
Global
From €3169EUR$3,600USD£2,742GBP
- Report
- September 2022
- 71 Pages
Europe
From €1320EUR$1,500USD£1,142GBP

The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more